{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:53:46Z","timestamp":1781794426567,"version":"3.54.5"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejmech.2026.118881","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:39:19Z","timestamp":1776728359000},"page":"118881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Etomidate derivatives: fine-tuning of molecular structure and innovation in pharmacological effects"],"prefix":"10.1016","volume":"313","author":[{"given":"Jiajia","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6962-2233","authenticated-orcid":false,"given":"Yin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118881_bib1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/sj.bjp.0700927","article-title":"J.J. Subunit-dependent interaction of the general anaesthetic etomidate with the gamma-aminobutyric acid type A receptor","volume":"120","author":"Hill-Venning","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118881_bib2","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1038\/sj.bjp.0706441","article-title":"Molecular targets underlying general anaesthesia","volume":"147","author":"Franks","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118881_bib3","first-page":"153","article-title":"Intravenous anesthetics in sepsis","volume":"43","author":"Tsao","year":"2005","journal-title":"Acta Anaesthesiol. Taiwanica"},{"key":"10.1016\/j.ejmech.2026.118881_bib4","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.annfar.2008.09.016","article-title":"Faut-il encore utiliser l'\u00e9tomidate ? [Should etomidate still be used?]","volume":"27","author":"Payen","year":"2008","journal-title":"Ann. Fr. Anesth. Reanim."},{"key":"10.1016\/j.ejmech.2026.118881_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/BF03005070","article-title":"Further experience with etomidate","volume":"25","author":"Famewo","year":"1978","journal-title":"Can. Anaesth. Soc. J."},{"key":"10.1016\/j.ejmech.2026.118881_bib6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1086\/701377","article-title":"GABA as a neurotransmitter in gastropod molluscs","volume":"236","author":"Miller","year":"2019","journal-title":"Biol. Bull."},{"key":"10.1016\/j.ejmech.2026.118881_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/805830","article-title":"GABA metabolism and transport: effects on synaptic efficacy","volume":"2012","author":"Roth","year":"2012","journal-title":"Neural Plast."},{"key":"10.1016\/j.ejmech.2026.118881_bib8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2165\/00003495-199550030-00008","article-title":"An update of its use in anaesthesia and conscious sedation","volume":"50","author":"Bryson","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2026.118881_bib9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/ACO.0000000000000916","article-title":"A versatile tool for anesthesia and analgesia","volume":"33","author":"Barrett","year":"2020","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"10.1016\/j.ejmech.2026.118881_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/637171","article-title":"Sedation in traumatic brain injury","volume":"2012","author":"Flower","year":"2012","journal-title":"Emerg Med Intern"},{"key":"10.1016\/j.ejmech.2026.118881_bib11","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1111\/ejn.12534","article-title":"GABAA receptors and plasticity of inhibitory neurotransmission in the central nervous system","volume":"39","author":"Fritschy","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118881_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.apha.2014.10.002","article-title":"Allosteric modulation of GABAA receptors via multiple drug-binding sites","volume":"72","author":"Sieghart","year":"2015","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118881_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40360-019-0328-4","article-title":"Behavioral and steroidogenic pharmacology of phenyl ring substituted etomidate analogs in rats","volume":"20","author":"McGrath","year":"2019","journal-title":"BMC. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2026.118881_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.11124\/JBIES-22-00390","article-title":"Pharmacological interventions for reducing the incidence of myoclonus in patients receiving etomidate for induction of general anesthesia: an umbrella review","volume":"22","author":"Greenwood","year":"2024","journal-title":"JBI Evid. Synth."},{"key":"10.1016\/j.ejmech.2026.118881_bib15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.7243\/2049-9752-2-2","article-title":"Pretreatment with butorphanol reduces myoclonus after etomidate","volume":"2","author":"Zhao","year":"2013","journal-title":"J. Anesthesiol. Clin. Sci."},{"key":"10.1016\/j.ejmech.2026.118881_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/bs.mie.2018.01.026","article-title":"Anesthetic drug discovery and development: a case study of novel etomidate analogs","volume":"603","author":"McGrath","year":"2018","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejmech.2026.118881_bib18","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJM198405313102202","article-title":"Inhibition of adrenal steroidogenesis by the anesthetic etomidate","volume":"310","author":"Wagner","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.118881_bib19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/ALN.0b013e3181cf40ed","article-title":"Carboetomidate: a pyrrole analog of etomidate designed not to suppress adrenocortical function","volume":"112","author":"Cotten","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejmech.2026.118881_bib16","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/ALN.0b013e3181ff72b5","article-title":"Clinical and molecular pharmacology of etomidate","volume":"114","author":"Forman","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejmech.2026.118881_bib25","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.csbj.2021.01.002","article-title":"Discovery of the EL-0052 as a potential anesthetic drug","volume":"19","author":"Jiang","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ejmech.2026.118881_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuropharm.2018.01.036","article-title":"GABAA receptor: positive and negative allosteric modulators","volume":"136","author":"Olsen","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2026.118881_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/AIA.0000000000000050","article-title":"The pharmacology of etomidate and etomidate derivatives","volume":"53","author":"Raines","year":"2015","journal-title":"Int. Anesthesiol. Clin."},{"key":"10.1016\/j.ejmech.2026.118881_bib22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-2044.2005.04518_2.x","article-title":"Etomidate--misused or misunderstood?","volume":"61","author":"Jackson","year":"2006","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ejmech.2026.118881_bib23","doi-asserted-by":"crossref","first-page":"282","DOI":"10.12968\/hmed.2016.77.5.282","article-title":"The role of etomidate as an anaesthetic induction agent for critically ill patients","volume":"77","author":"Allen","year":"2016","journal-title":"Br. J. Hosp. Med."},{"key":"10.1016\/j.ejmech.2026.118881_bib24","article-title":"The etomidate analog ET-26 HCl retains superior myocardial performance: comparisons with etomidate in vivo and in vitro","volume":"13","author":"Song","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.118881_bib26","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/ALN.0000000000002356","article-title":"Etomidate and etomidate analog binding and positive modulation of \u03b3-Aminobutyric acid type A receptors: evidence for a state-dependent cutoff effect","volume":"129","author":"McGrath","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejmech.2026.118881_bib27","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.1021\/jm100498u","article-title":"P-Trifluoromethyldiazirinyl-etomidate: a potent photoreactive general anesthetic derivative of etomidate that is selective for ligand-gated cationic ion channels","volume":"53","author":"Husain","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118881_bib28","doi-asserted-by":"crossref","first-page":"760","DOI":"10.2174\/156802611795165098","article-title":"The significance of chirality in drug design and development","volume":"11","author":"Brooks","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118881_bib29","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1021\/jm00326a017","article-title":"DL-1-(1-arylalkyl) imidazole-5-carboxylate esters. A novel type of hypnotic agents","volume":"8","author":"Godefroi","year":"1965","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118881_bib31","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/ALN.0000000000000268","article-title":"Analogues of etomidate: modifications around etomidate's chiral carbon and the impact on in vitro and in vivo pharmacology","volume":"121","author":"Pejo","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejmech.2026.118881_bib30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/ALN.0000000000001662","volume":"127","author":"Struys","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejmech.2026.118881_bib32","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/jcem-59-6-1143","article-title":"Etomidate suppresses adrenocortical function by inhibition of 11 beta-hydroxylation","volume":"59","author":"de Jong","year":"1984","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejmech.2026.118881_bib33","doi-asserted-by":"crossref","first-page":"39437","DOI":"10.1074\/jbc.M607665200","article-title":"Crystal structure of the Mycobacterium tuberculosis P450 CYP121-fluconazole complex reveals new azole drug-P450 binding mode","volume":"281","author":"Seward","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118881_bib34","doi-asserted-by":"crossref","first-page":"27294","DOI":"10.1074\/jbc.M403349200","article-title":"Structure of mammalian cytochrome P450 2B4 complexed with 4-(4-chlorophenyl)imidazole at 1.9-A resolution: insight into the range of P450 conformations and the coordination of redox partner binding","volume":"279","author":"Scott","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118881_bib35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/ALN.0000000000002758","article-title":"Toxicologic and inhibitory receptor actions of the etomidate analog ABP-700 and its metabolite CPM-acid","volume":"131","author":"Valk","year":"2019","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejmech.2026.118881_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/ALN.0000000000003590","article-title":"Modeling the effect of excitation on depth of anesthesia monitoring in \u03b3-Aminobutyric acid type A receptor agonist ABP-700","volume":"134","author":"Valk","year":"2021","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.ejmech.2026.118881_bib37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0750-7658(05)80050-4","article-title":"Pharmacokinetics of etomidate","volume":"9","author":"Levron","year":"1990","journal-title":"Ann. Fr. Anesth. Reanim."},{"key":"10.1016\/j.ejmech.2026.118881_bib38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1213\/ANE.0b013e3182320559","article-title":"In vivo and in vitro pharmacological studies of methoxycarbonyl-carboetomidate","volume":"115","author":"Pejo","year":"2012","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejmech.2026.118881_bib39","unstructured":"Chengdu Anuo Morning Innovation Pharmaceutical Technology Co., Ltd. Substituted Pyrrolidone Ester Derivatives and their Applications[P]. CN: CN110003188A, 2022-08-26."},{"key":"10.1016\/j.ejmech.2026.118881_bib40","unstructured":"Chengdu Ma Fei San Pharmaceutical Technology Co., Ltd. Highly Substituted Triazole Carboxylate Derivatives and their Applications[P]. CN: CN110669017A. 2023-08-04."},{"key":"10.1016\/j.ejmech.2026.118881_bib41","unstructured":"Chengdu Ma Fei San Pharmaceutical Technology Co., Ltd. Substituted Pyrazole Carboxylate Ester Derivatives and their Applications[P]. CN: CN110724106B. 2023-05-05."},{"key":"10.1016\/j.ejmech.2026.118881_bib42","doi-asserted-by":"crossref","first-page":"15706","DOI":"10.1073\/pnas.1822076116","article-title":"A newly developed anesthetic based on a unique chemical core","volume":"116","author":"Cayla","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2026.118881_bib43","unstructured":"Jiangsu Enhua Luokang Pharmaceutical R&D Co., Ltd. Etomidate Derivatives and Their Intermediates, Preparation Methods, and Applications[P]. WO: WO2017059827A1. 2017-04-13."},{"key":"10.1016\/j.ejmech.2026.118881_bib44","unstructured":"Chengdu Ma Fei San Pharmaceutical Technology Co., Ltd. Highly Substituted Imidazole Carboxylate Ester Derivatives and their Applications[P]. CN: CN109824656B. 2023-11-10."},{"key":"10.1016\/j.ejmech.2026.118881_bib45","unstructured":"Chongqing Maidi Sheng Pharmaceutical Technology Co., Ltd. A Class of Halogenated Imidazole Compounds, Preparation Methods, and Applications[P]. CN: CN110655490A. 2020-01-07."},{"key":"10.1016\/j.ejmech.2026.118881_bib46","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.2174\/138161212803832362","article-title":"Novel etomidate derivatives","volume":"18","author":"Sneyd","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2026.118881_bib47","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/ALN.0b013e3181ae63d1","article-title":"Methoxycarbonyl-etomidate: a novel rapidly metabolized and ultra-short-acting etomidate analogue that does not produce prolonged adrenocortical suppression","volume":"111","author":"Cotten","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejmech.2026.118881_bib48","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1213\/ANE.0b013e318239c6ca","article-title":"Pharmacological studies of methoxycarbonyl etomidate's carboxylic acid metabolite","volume":"115","author":"Ge","year":"2012","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejmech.2026.118881_bib49","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/ALN.0b013e31821950de","article-title":"Closed-loop continuous infusions of etomidate and etomidate analogs in rats: a comparative study of dosing and the impact on adrenocortical function","volume":"115","author":"Cotten","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejmech.2026.118881_bib50","unstructured":"Chengdu Ma Fei San Pharmaceutical Technology Co., Ltd. A N-Substituted Imidazole Carboxylate Ester Derivative and its Applications[P]. CN: CN109776512A. 2019-05-21."},{"key":"10.1016\/j.ejmech.2026.118881_bib51","unstructured":"Sichuan University West China Hospital, N-Substituted Imidazole Carboxylate Ester Compounds with ultra-short-acting Anesthetic Effects, Preparation Methods, and Applications[P]. CN: CN103588757A. 2014-11-12."},{"key":"10.1016\/j.ejmech.2026.118881_bib52","unstructured":"Yuanda Medical Nutrition Science (Wuhan) Co., Ltd, Imidazole Derivatives and their Applications[P]. CN: CN118084796A. 2024-05-28."},{"key":"10.1016\/j.ejmech.2026.118881_bib53","unstructured":"Yuanda Medical Nutrition Science (Wuhan) Co., Ltd, Imidazole Derivatives and their Applications[P]. CN: CN118812439A. 2024-10-22."},{"key":"10.1016\/j.ejmech.2026.118881_bib54","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.4103\/2152-7806.109179","article-title":"Anesthetic drug development: novel drugs and new approaches","volume":"4","author":"Eckenhoff","year":"2013","journal-title":"Surg. Neurol. Int."},{"key":"10.1016\/j.ejmech.2026.118881_bib55","series-title":"Total Intravenous Anesthesia and Target Controlled Infusions","author":"Absalom","year":"2017"},{"key":"10.1016\/j.ejmech.2026.118881_bib56","doi-asserted-by":"crossref","DOI":"10.1007\/s40262-021-01038-6","article-title":"Etomidate and its analogs: a review of pharmacokinetics and pharmacodynamics","author":"Valk","year":"2021","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2026.118881_bib57","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1124\/jpet.121.000691","article-title":"A novel etomidate analog EL-0052 retains potent hypnotic effect and stable hemodynamics without suppressing adrenocortical function","volume":"379","author":"Xu","year":"2021","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2026.118881_bib58","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.1021\/jm100498u","article-title":"P-Trifluoromethyldiazirinyl-etomidate: a potent photoreactive general anesthetic derivative of etomidate that is selective for ligand-gated cationic ion channels","volume":"53","author":"Husain","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118881_bib59","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/ALN.0000000000000721","article-title":"Cyclopropyl-methoxycarbonyl metomidate: studies in a lipopolysaccharide inflammatory model of sepsis","volume":"123","author":"Santer","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejmech.2026.118881_bib60","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/ALN.0000000000000416","article-title":"Advancing novel anesthetics: pharmacodynamic and pharmacokinetic studies of cyclopropyl-methoxycarbonyl metomidate in dogs","volume":"121","author":"Campagna","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejmech.2026.118881_bib61","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1213\/ANE.0000000000000069","article-title":"The pharmacology of cyclopropyl-methoxycarbonyl metomidate: a comparison with propofol","volume":"118","author":"Ge","year":"2014","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejmech.2026.118881_bib62","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.bja.2018.01.038","article-title":"Safety and clinical effect of i.v. infusion of cyclopropyl-methoxycarbonyl etomidate (ABP-700), a soft analogue of etomidate, in healthy subjects","volume":"120","author":"Valk","year":"2018","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejmech.2026.118881_bib63","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1021\/bi201772m","article-title":"Mapping general anesthetic binding site(s) in human \u03b11\u03b23 \u03b3-aminobutyric acid type A receptors with [3H]TDBzl-etomidate, a photoreactive etomidate analogue","volume":"51","author":"Chiara","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2026.118881_bib64","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejps.2016.12.041","article-title":"Metabolite-inactive etomidate analogues alleviating suppression on adrenal function in beagle dogs","volume":"99","author":"Yang","year":"2017","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2026.118881_bib65","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejps.2017.09.005","article-title":"Pharmacologic studies on ET-26 hydrochloride in a rat model of lipopolysaccharide-induced sepsis","volume":"109","author":"Wang","year":"2017","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2026.118881_bib66","article-title":"26 hydrochloride (ET-26 HCl) has similar hemodynamic stability to that of etomidate in normal and uncontrolled hemorrhagic shock (UHS) rats","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.118881_bib67","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/j.jvca.2021.01.034","article-title":"Etomidate and adrenocortical suppression: should we take the concerns to heart?","volume":"35","author":"Dalia","year":"2021","journal-title":"J. Cardiothorac. Vasc. Anesth."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426003260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426003260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:18:21Z","timestamp":1781792301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426003260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":67,"alternative-id":["S0223523426003260"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118881","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Etomidate derivatives: fine-tuning of molecular structure and innovation in pharmacological effects","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118881","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118881"}}